TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Faun Pharma AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
177,892
|
155,112
|
147,644 |
| Financial expenses |
546
|
586
|
301 |
| Earnings before taxes |
7,619
|
6,253
|
2,991 |
| Total assets |
59,956
|
49,581
|
48,213 |
| Current assets |
48,361
|
39,211
|
36,040 |
| Current liabilities |
14,288
|
10,767
|
11,784 |
| Equity capital |
33,596
|
28,122
|
24,860 |
| - share capital |
970
|
987
|
1,057 |
| Employees (average) | 41 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.0%
|
56.7%
|
51.6% |
| Turnover per employee | 3,601 | ||
| Profit as a percentage of turnover |
4.3%
|
4.0%
|
2.0% |
| Return on assets (ROA) |
13.6%
|
13.8%
|
6.8% |
| Current ratio |
338.5%
|
364.2%
|
305.8% |
| Return on equity (ROE) |
22.7%
|
22.2%
|
12.0% |
| Change turnover |
25,528
|
17,250
|
-23,543 |
| Change turnover % |
17%
|
13%
|
-14% |
| Chg. No. of employees | 3 | ||
| Chg. No. of employees % | 8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.